Recombinant人GTF2A1 protein (ab81932)

概述

描述

  • 性质Recombinant
  • 来源Escherichia coli
  • 氨基酸序列
    • 种属Human

技术指标

Our Abpromise guarantee covers the use of ab81932 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • 应用

    SDS-PAGE

  • 纯度> 95 % SDS-PAGE.

  • 形式Liquid
  • Concentration information loading...

制备和贮存

  • 稳定性和存储

    Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.

    Preservative: None
    Constituents: 20% Glycerol, 20mM Tris HCl, 100mM Potassium chloride, 1mM DTT, 0.2mM EDTA, pH 8.0

常规信息

  • 别名
    • General transcription factor IIA 1 19/37kDa
    • General transcription factor IIA subunit 1
    • General transcription factor IIA1
    • Glucose regulated protein 58kD pseudogene
    • gtf2a1
    • TF2A1
    • TF2AA_HUMAN
    • TFIIA 42
    • TFIIA alpha p55
    • TFIIA alpha p55, isoform 1
    • TFIIA p19 subunit
    • TFIIA p35 subunit
    • TFIIA-42
    • TFIIAL
    • Transcription initiation factor IIA beta chain
    • Transcription initiation factor IIA subunit 1
    • Transcription initiation factor TFIIA 42 kDa subunit
    see all
  • 功能TFIIA is a component of the transcription machinery of RNA polymerase II and plays an important role in transcriptional activation. TFIIA in a complex with TBP mediates transcriptional activity.
  • 序列相似性Belongs to the TFIIA subunit 1 family.
  • 翻译后修饰The alpha and beta subunits are postranslationally produced from the precursor form by TASP1. The cleavage promotes proteasomal degradation.
  • 细胞定位Nucleus.
  • Information by UniProt

Recombinant Human GTF2A1 protein (ab81932)参考文献

ab81932 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab81932.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"